Shubh Goel, Vice President, Global Franchise Head for BiSpecifics at AstraZeneca, shared a post on LinkedIn:
“Eliminating cancer as a cause of death is a goal shared across the globe – but no one country, company or stakeholder can do it alone.
Bold and unexpected collaborations can push cancer care boundaries, yielding far-reaching outcomes that benefit patients, health systems and society.
Learn more in this article by my colleague, David Fredrickson, EVP, Oncology Hematology Business Unit.”
